FindTrial
Sign In

CyberKnife Stereotactic Radiosurgery

RADIATION5 trials

Sponsors

Accuray Incorporated, Stanford University, Swedish Medical Center, Peking University Third Hospital

Conditions

Cancer of the ProstateNon-small Cell Lung CancerProstate CancerProstate NeoplasmsProstatic CancerProstatic NeoplasmsSpinal NeoplasmsTrigeminal Neuralgia

Phase 2

CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer
NCT00643318
Accuray IncorporatedNon-small Cell Lung Cancer
Start: 2006-04-30End: 2021-12-31Updated: 2021-03-05

Phase 3

A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia
TerminatedNCT01364259
Stanford UniversityTrigeminal Neuralgia
Start: 2008-09-30End: 2015-01-31Updated: 2017-04-04

Unknown Phase

CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
CompletedNCT00643994
Accuray IncorporatedCancer of the Prostate, Prostate Cancer, Prostate Neoplasms +2
Start: 2007-12-31End: 2021-01-27Updated: 2023-05-09
Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer
NCT02334579
Swedish Medical CenterCancer of the Prostate, Prostate Cancer, Prostate Neoplasms +2
Start: 2014-12-31End: 2024-12-31Target: 146Updated: 2019-07-12
Evaluation of Effectiveness of CyberKnife Stereotactic Radiosurgery for Spinal Tumors
NCT04192383
Peking University Third HospitalSpinal Neoplasms
Start: 2018-09-01End: 2022-01-01Target: 60Updated: 2021-06-29